Position in BMY
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,137,951,021
+$153,963,574 QoQ
Shares Held
18,762,589
+2.9% QoQ
Ownership
0.919%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 80.0308955230006.ToString("F0")%
Shared 12.543343565219065.ToString("F0")%
None 7.425760911780352.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $16,975,027,289 across 14 Drug Manufacturers - General names. BMY ranks #7 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,832,514 | $3,870,099,719 | |
| 2 | LLY |
ELI LILLY & Co
|
3,895,925 | $3,583,354,934 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,456,039 | $1,859,206,929 | |
| 4 | ABBV |
AbbVie Inc.
|
7,411,238 | $1,611,870,150 | |
| 5 | NVS |
Novartis AG
|
8,110,116 | $1,238,820,217 | |
| 6 | AMGN |
Amgen Inc
|
3,304,344 | $1,162,633,435 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
18,762,589 | $1,137,951,021 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,722,929 | $1,076,344,612 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,137,951,021 | 18,762,589 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $983,987,447 | 18,242,259 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $818,279,605 | 18,143,672 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $753,140,798 | 16,270,054 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $815,535,407 | 13,371,625 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $774,781,502 | 13,698,400 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $583,676,040 | 11,280,944 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $584,115,128 | 14,064,896 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $903,002,924 | 16,651,354 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $870,207,694 | 16,959,807 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $912,025,525 | 15,713,741 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $900,540,763 | 14,081,951 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $907,170,447 | 13,088,594 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $907,637,591 | 12,614,838 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,042,178,119 | 14,659,982 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,116,818,549 | 14,504,137 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,005,824,151 | 13,772,753 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $798,632,358 | 12,808,859 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $690,985,307 | 11,677,967 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $734,918,032 | 10,998,474 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $563,895,152 | 8,932,285 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $544,506,473 | 8,778,115 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $516,840,486 | 8,572,574 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $503,879,132 | 8,569,373 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $447,177,104 | 8,022,553 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||